Advantages for the use of the activated clotting time (ACT)
D001158:Arteries; D003327:Coronary Disease / Q000188:drug therapy*; D016903:Drug Monitoring / Q000379:methods*; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D014680:Veins; D014914:Whole Blood Coagulation Time
D006493:Heparin